Riskpilot← Back to searchSign inGet full accessWandas Consulting AB
ABActiveOrg 5593682056Vombsjögatan 16Medical specialists activities · NACE 8622Est. 20220 employees
Revenue 2025
SEK 370K
+158% vs 2024
EBITDA margin
45.8%
+173% vs 2024
Equity ratio
42.9%
Financial strength
Net profit 2025
SEK 134K
+162% vs 2024
| Revenue | SEK 370K | +158% |
| EBITDA | SEK 170K | +173% |
| Net profit | SEK 134K | +162% |
| Total assets | SEK 534K | +65% |
| Equity | SEK 229K | +142% |
| Employees | 0 | — |
Legal name
Wandas Consulting AB
Org number
5593682056
Legal form
Aktiebolag
NACE code
8622 · Medical specialists activities
Founded
1 mars 2022
Share capital
SEK 25 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Konsultverksamhet inom hälsovård och sjukvård, läkarbedömningar både fysiskt och digitalt inom sjukhus och primärvård, resemedicin, akutmedicin, sportmedicin samt försäkringsmedicin. Uthyrning av narkos samt intensivvårdstjänster till privat och officiell verksamhet. Utbildningsverksamhet inom samma områden. Handling och förvaltning av värdepapper och fastigheter, samt därmed förenlig verksamhet.
Address
Vombsjögatan 16
Email
marzenawandas1@gmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Revenue | 380 | 56 | 144 | 370 |
| Staff expenses | −1 | −1 | −7 | −23 |
| EBITDA | 331 | 27 | 62 | 170 |
| Depreciation & amort. | — | — | — | — |
| EBIT | 331 | 27 | 62 | 170 |
| Net financials | 0 | 3 | 3 | 1 |
| Profit before tax | 251 | 30 | 65 | 171 |
| Tax | −52 | −7 | −14 | −36 |
| Net profit | 199 | 23 | 51 | 134 |
| Item | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Total assets | 334 | 351 | 323 | 534 |
| Equity | 224 | 247 | 95 | 229 |
| Long-term debt | — | — | — | — |
| Short-term debt | 30 | 24 | 149 | 225 |
| Total debt | 30 | 24 | 149 | 225 |
EBITDA margin
45.8%
This company
15.8%
Market median
+190% vs market
20222025
Equity ratio
42.9%
This company
38.2%
Market median
+12% vs market
20222025
Return on equity
58.7%
This company
18.4%
Market median
+219% vs market
20222025
Net profit margin
36.3%
This company
8.1%
Market median
+348% vs market
20222025
Asset turnover
0.69×
This company
1.12×
Market median
-38% vs market
20222025
Debt / equity
1.33×
This company
0.62×
Market median
-115% vs market
20222025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-03-01 – 2022-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Board of Directors | 2022 | |
| Deputy Board Member | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Wandas Consulting AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Marzena Wandas | Board of Directors | 0 companies |
| Norbert Janusz Wandas | Deputy Board Member | 0 companies |